Buscar resultados de ensayos clínicos

Patrocinado por

Hairy Cell Leukemia - 25 Studies Found

Estado Estudiar
Completed Nombre del estudio: Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia
Condición: Leukemia
Fecha: 2001-08-10
Intervenciones: Biological: BL22 immunotoxin
Recruiting Nombre del estudio: Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
Condición:
  • Hairy Cell Leukemia (HCL)
  • Chronic Lymphocytic Leukemia (CLL) Fecha: 2010-03-13
Completed Nombre del estudio: Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery
Condición:
  • Adult Acute Lymphoblastic Leukemia in Remission
  • Adult B Acute Lymphoblastic Leukemia
    • Fecha: 2008-01-30
    Intervenciones:
    • Drug: Dasatinib Given PO
Active, not recruiting Nombre del estudio: Bortezomib and Filgrastim in Promoting Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma Undergoing Stem Cell Transplant
Condición:
  • Adult Grade III Lymphomatoid Granulomatosis
  • B-cell Chronic Lymphocytic Leukemia
  • Fecha: 2014-01-14
    Intervenciones:
    • Drug: bortezomib Given IV
COMPLETED Nombre del estudio: BRAF Inhibitor, Vemurafenib, in Patients With Relapsed or Refractory Hairy Cell Leukemia
Condición: Hairy Cell Leukemia
Fecha: 2025-11-04
Intervenciones: Patients will receive vemurafenib at a dose of 960mg orally b.i.d.continuously in cycles of 4 weeks (28 days) as outpatient.A bone marrow
<<< Previous